| Conferences \ European Lab Automation \ Screening Europe - HCS and Assays \ Agenda \ Michael Holinstat |
| Register | Login |
12-lipoxygenase Regulation of Pro and Anti-thrombotic Effects in Human Platelets: Two Approaches to Novel Anti-platelet TherapyFriday, 1 July 2011 at 11:15  Add to Calendar ▼2011-07-01 11:15:002011-07-01 12:15:00Europe/London12-lipoxygenase Regulation of Pro and Anti-thrombotic Effects in Human Platelets: Two Approaches to Novel Anti-platelet TherapySELECTBIOenquiries@selectbiosciences.comNovel anti-platelet therapies are needed to treat unwanted platelet aggregation leading to vessel occlusion and stroke. Our screens have identified several potential therapeutic targets to address this need including inhibition of 12-lipoxygenase and regulation of oxidized metabolites in the platelet. |
Add to Calendar ▼2011-06-30 00:00:002011-07-01 00:00:00Europe/LondonScreening Europe - HCS and AssaysSELECTBIOenquiries@selectbiosciences.com
